Rethinking Head Computed Tomography (CT) in the Emergency Department: From Reflex Imaging to Reasoned Care
Rationale for Reevaluation In recent years, there has been a growing recognition that the traditional approach to head computed tomography […]
Treatment Discontinuation in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Treatment Patterns Treatment patterns in patients diagnosed with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) often involve immunomodulatory therapies, which have
Decisive role of brain biopsy in atypical tumefactive demyelinating lesions: A case report
Study Overview The investigation centers on the role of brain biopsy in diagnosing atypical tumefactive demyelinating lesions, which can often
Blood Biomarkers for Identifying Epidural Hematoma in Patients Presenting with a Glasgow Coma Scale of 13-15: A Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study
Study Overview This investigation focuses on the role blood biomarkers play in the diagnosis of epidural hematomas among patients who
Free water changes and their correlations with multimodal biomarkers in frontotemporal dementia
Study Overview The investigation into the role of free water changes in frontotemporal dementia (FTD) explores how these fluctuations correlate
Pediatric-Onset Multiple Sclerosis Presenting With Persistent Vertigo, Ataxia, and Optic Nerve Atrophy in a 15-Year-Old Girl: A Case Report
Study Overview The case report highlights an unusual presentation of pediatric-onset multiple sclerosis (POMS) in a 15-year-old female patient who
Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis
Endocannabinoid System and Multiple Sclerosis The endocannabinoid system (ECS) consists of a network of receptors, endogenous cannabinoids, and metabolic enzymes
Pediatric-Onset Multiple Sclerosis Presenting With Persistent Vertigo, Ataxia, and Optic Nerve Atrophy in a 15-Year-Old Girl: A Case Report
Background and Context Multiple sclerosis (MS) is a chronic autoimmune disease that predominantly affects the central nervous system (CNS), characterized
Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis
Case Studies and Observations Recent inquiries into the utilization of the endocannabinoid system for managing residual disease in relapse-free multiple
Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis
Endocannabinoid System Mechanisms The endocannabinoid system (ECS) plays a pivotal role in maintaining homeostasis within the body and has garnered